Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.

Scott DL, White SP, Browning JL, Rosa JJ, Gelb MH, Sigler PB.

Science. 1991 Nov 15;254(5034):1007-10.

PMID:
1948070
2.

Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution.

Wery JP, Schevitz RW, Clawson DK, Bobbitt JL, Dow ER, Gamboa G, Goodson T Jr, Hermann RB, Kramer RM, McClure DB, et al.

Nature. 1991 Jul 4;352(6330):79-82.

PMID:
2062381
3.

Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.

Kitadokoro K, Hagishita S, Sato T, Ohtani M, Miki K.

J Biochem. 1998 Apr;123(4):619-23.

4.
5.

X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.

Thunnissen MM, Ab E, Kalk KH, Drenth J, Dijkstra BW, Kuipers OP, Dijkman R, de Haas GH, Verheij HM.

Nature. 1990 Oct 18;347(6294):689-91.

PMID:
2215698
6.

Three-dimensional structures of human phospholipase A2 from pancreas and synovial fluid by model building.

Christensen IT, Jørgensen FS, Svensson LA, Högberg T.

Drug Des Discov. 1993 Jun;10(2):101-13.

PMID:
8399996
7.

Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue.

White SP, Scott DL, Otwinowski Z, Gelb MH, Sigler PB.

Science. 1990 Dec 14;250(4987):1560-3.

PMID:
2274787
8.

Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states.

Vadas P, Browning J, Edelson J, Pruzanski W.

J Lipid Mediat. 1993 Aug;8(1):1-30. Review.

PMID:
8257775
9.

Inhibition of human secretory class II phospholipase A2 by heparin.

Dua R, Cho W.

Eur J Biochem. 1994 Apr 1;221(1):481-90.

10.

Characterization of extracellular phospholipase A2 (PLA2) activity in fluid and peritoneal cells from casein-treated rats.

Stevens TM, McGowan M, Giannaras J, Kerr JS.

Inflammation. 1990 Aug;14(4):389-99.

PMID:
2379954
11.

Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.

Singh N, Jabeen T, Sharma S, Somvanshi RK, Dey S, Srinivasan A, Singh TP.

Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):410-6. Epub 2006 Mar 18.

PMID:
16552142
12.

High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2).

Bridonneau P, Chang YF, O'Connell D, Gill SC, Snyder DW, Johnson L, Goodson T Jr, Herron DK, Parma DH.

J Med Chem. 1998 Mar 12;41(6):778-86.

PMID:
9526554
13.

Crystal structure analysis of phospholipase A2 from trimeresurus flavoviridis (Habu snake) venom at 1.5 A resolution.

Suzuki A, Matsueda E, Yamane T, Ashida T, Kihara H, Ohno M.

J Biochem. 1995 Apr;117(4):730-40.

14.

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2.

Schevitz RW, Bach NJ, Carlson DG, Chirgadze NY, Clawson DK, Dillard RD, Draheim SE, Hartley LW, Jones ND, Mihelich ED, et al.

Nat Struct Biol. 1995 Jun;2(6):458-65.

PMID:
7664108
15.
16.

Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue.

Scott DL, Otwinowski Z, Gelb MH, Sigler PB.

Science. 1990 Dec 14;250(4987):1563-6. Erratum in: Science 1991 May 10;252(5007):764.

PMID:
2274788
18.
20.

The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution.

Holland DR, Clancy LL, Muchmore SW, Ryde TJ, Einspahr HM, Finzel BC, Heinrikson RL, Watenpaugh KD.

J Biol Chem. 1990 Oct 15;265(29):17649-56.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk